Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells
出版年份 2020 全文链接
标题
Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-29
DOI
10.1038/s41598-020-72538-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells
- (2020) Yasuko Yamamoto et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Cystoid macula edema related to cataract surgery and topical prostaglandin analogs: mechanism, diagnosis, and management
- (2020) Gábor Holló et al. SURVEY OF OPHTHALMOLOGY
- Prostaglandin F2α agonist-induced suppression of 3T3-L1 cell adipogenesis affects spatial formation of extra-cellular matrix
- (2020) Yosuke Ida et al. Scientific Reports
- Omidenepag Isopropyl Versus Latanoprost in Primary Open-angle Glaucoma and Ocular Hypertension: ThePhase 3 AYAME Study
- (2020) Makoto Aihara et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma
- (2018) Francesco Impagnatiello et al. BRITISH JOURNAL OF PHARMACOLOGY
- Collagen VI in healthy and diseased nervous system
- (2018) Ilaria Gregorio et al. Disease Models & Mechanisms
- Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys
- (2018) Masahiro Fuwa et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Omidenepag Isopropyl Ophthalmic Solution 0.002%: First Global Approval
- (2018) Sean Duggan DRUGS
- A current perspective of canstatin, a fragment of type IV collagen alpha 2 chain
- (2018) Muneyoshi Okada et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Extracellular matrix assembly: a multiscale deconstruction
- (2014) Janna K. Mouw et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Remodelling the extracellular matrix in development and disease
- (2014) Caroline Bonnans et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension
- (2012) Ronald A. Schachar et al. CURRENT EYE RESEARCH
- Deepening of the Upper Eyelid Sulcus Caused by 5 Types of Prostaglandin Analogs
- (2012) Kenji Inoue et al. JOURNAL OF GLAUCOMA
- Peri-adipocyte ECM remodeling in obesity and adipose tissue fibrosis
- (2012) Tae-Hwa Chun Adipocyte
- Effect of PF-04217329 a prodrug of a selective prostaglandin EP2 agonist on intraocular pressure in preclinical models of glaucoma
- (2011) Ganesh Prasanna et al. EXPERIMENTAL EYE RESEARCH
- Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost
- (2011) Juwan Park et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- From 3D cell culture to organs-on-chips
- (2011) Dongeun Huh et al. TRENDS IN CELL BIOLOGY
- Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: A prospective, observational, noninterventional study
- (2010) Oliver Schwenn et al. BMC Ophthalmology
- Periorbital Changes Associated With Topical Bimatoprost
- (2009) Theodoros Filippopoulos et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators
- (2008) Karl E Kadler et al. CURRENT OPINION IN CELL BIOLOGY
- Orbitale Fettgewebsatrophie bei lokaler Bimatoprost-Therapie - Kann Bimatoprost einen Enophthalmus verursachen?
- (2008) C Tappeiner et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now